Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234897 · ClinicalTrials.gov registry record · Phase 4
Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,938
- Enrollment target
NCT00234897: Completed Phase 4 study, sponsored by Abbott.
NCT00234897 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 1,938 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (274% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00234897, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,938 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Interventions
- DRUG adalimumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,938 participants |
| Start Date | 2004-08 |
| Phase | Phase 4 |
What the finished NCT00234897 record still lists
NCT00234897 is an interventional study that assigns participants to a tested intervention. Its 1,938 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (274% higher).
The record links to 0 conditions, and to 1 intervention - of which adalimumab is the first listed.
NCT00234897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00234897 about?
NCT00234897 is a clinical study titled "Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis". The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
What is the current status of trial NCT00234897?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,938 participants. The study started on 2004-08.
What interventions are being tested in trial NCT00234897?
The interventions under investigation include: adalimumab (DRUG).
Who is sponsoring clinical trial NCT00234897?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00234897's enrollment target sits among peer trials
1,938 44th of 2000 higher than 1,957 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia